GABA physiology: modulation by benzodiazepines and hormones

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Benzodiazepines (BZs) and neurosteroids interact with the gamma-aminobutyric acid (GABA) receptor complex.
• Gonadal steroids exhibit varied effects on neuronal excitability, mirroring BZ pharmacology.

Purpose of the Study:

• To compare the effects of acute and chronic benzodiazepine treatments, gonadal hormones, and neurosteroids on physiological GABA responses in animals.
• To investigate region-specific adaptations and tolerance development to chronic BZ treatments.

Main Methods:

• Review of existing literature on animal studies examining BZ and steroid modulation of GABAergic neurotransmission.
• Comparison of neuronal responses across various brain regions (spinal cord, hippocampus, amygdala, etc.).

Main Results:

• Both BZs and neurosteroids directly modulate GABA responses.
• Acute and chronic BZ treatments induce region-specific effects on GABAergic responses.
• Chronic BZ treatment leads to tolerance via mechanisms like intrinsic subsensitivity and altered neuronal properties.
• Progesterone, via its metabolite 3 alpha-OH DHP, potentiates GABA responses in a BZ-like manner.
• Estrogen's effects on GABA neurotransmission are indirect, primarily influencing excitatory neurotransmitter systems.

Conclusions:

• Benzodiazepines and neurosteroids are significant modulators of GABAergic systems.
• Chronic BZ use leads to complex, region-specific adaptations and tolerance.
• Neurosteroids, particularly progesterone metabolites, show promise as GABAergic modulators.
• Estrogens influence neuronal excitability through non-GABAergic pathways.